186 related articles for article (PubMed ID: 30349208)
21. A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study).
Staskin D; Herschorn S; Fialkov J; Tu LM; Walsh T; Schermer CR
Int Urogynecol J; 2018 Feb; 29(2):273-283. PubMed ID: 28620791
[TBL] [Abstract][Full Text] [Related]
22. Patient Preferences for Bariatric Surgery: Findings From a Survey Using Discrete Choice Experiment Methodology.
Rozier MD; Ghaferi AA; Rose A; Simon NJ; Birkmeyer N; Prosser LA
JAMA Surg; 2019 Jan; 154(1):e184375. PubMed ID: 30484820
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study.
Chuang YC; Liu SP; Lee KS; Liao L; Wang J; Yoo TK; Chu R; Sumarsono B
Low Urin Tract Symptoms; 2019 Jan; 11(1):48-55. PubMed ID: 28967230
[TBL] [Abstract][Full Text] [Related]
24. Relative Importance of Mode of Administration in Treatment Preferences among Plaque Psoriasis Patients in the United States.
Feldman SR; Holmen Moeller A; Erntoft Idemyr ST; González JM
J Health Econ Outcomes Res; 2017; 4(2):141-157. PubMed ID: 37661952
[No Abstract] [Full Text] [Related]
25. Patient preferences for different severities of and treatments for overactive bladder.
Wu JM; Fulton RG; Amundsen CL; Knight SK; Kuppermann M
Female Pelvic Med Reconstr Surg; 2011 Jul; 17(4):184-9. PubMed ID: 22453849
[TBL] [Abstract][Full Text] [Related]
26. Health-related consequences of overactive bladder.
Wagner TH; Hu TW; Bentkover J; LeBlanc K; Stewart W; Corey R; Zhou Z; Hunt T
Am J Manag Care; 2002 Dec; 8(19 Suppl):S598-607. PubMed ID: 12516954
[TBL] [Abstract][Full Text] [Related]
27. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
[TBL] [Abstract][Full Text] [Related]
28. Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder.
Ricci JA; Baggish JS; Hunt TL; Stewart WF; Wein A; Herzog AR; Diokno AC
Clin Ther; 2001 Aug; 23(8):1245-59. PubMed ID: 11558861
[TBL] [Abstract][Full Text] [Related]
29. Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments.
Heisen M; Baeten SA; Verheggen BG; Stoelzel M; Hakimi Z; Ridder A; van Maanen R; Stolk EA
Curr Med Res Opin; 2016; 32(4):787-96. PubMed ID: 26789823
[TBL] [Abstract][Full Text] [Related]
30. Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.
Swift SE; Siami P; Forero-Schwanhaeuser S
Clin Drug Investig; 2009; 29(5):305-16. PubMed ID: 19366272
[TBL] [Abstract][Full Text] [Related]
31. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
[TBL] [Abstract][Full Text] [Related]
32. Sleep Disturbance and Fatigue Are Associated With More Severe Urinary Incontinence and Overactive Bladder Symptoms.
Ge TJ; Vetter J; Lai HH
Urology; 2017 Nov; 109():67-73. PubMed ID: 28826875
[TBL] [Abstract][Full Text] [Related]
33. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
[TBL] [Abstract][Full Text] [Related]
34. A Narrative Review of Patient-reported Outcomes in Overactive Bladder: What is the Way of the Future?
Chapple CR; Kelleher CJ; Evans CJ; Kopp Z; Siddiqui E; Johnson N; Mako M
Eur Urol; 2016 Nov; 70(5):799-805. PubMed ID: 27160948
[TBL] [Abstract][Full Text] [Related]
35. Patient Preferences for Endometriosis Pain Treatments in the United States.
Poulos C; Soliman AM; Renz CL; Posner J; Agarwal SK
Value Health; 2019 Jun; 22(6):728-738. PubMed ID: 31198191
[TBL] [Abstract][Full Text] [Related]
36. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).
Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M
Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014
[TBL] [Abstract][Full Text] [Related]
37. Qualitative Analysis of Factors Influencing Patient Persistence and Adherence to Prescribed Overactive Bladder Medication in UK Primary Care.
Ali M; Grogan S; Powell S; Staniford L; Nazir J; Landeira M; Covernton PJO; Jaggi A; Fatoye F; Holt M
Adv Ther; 2019 Nov; 36(11):3110-3122. PubMed ID: 31559603
[TBL] [Abstract][Full Text] [Related]
38. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment.
Turk D; Boeri M; Abraham L; Atkinson J; Bushmakin AG; Cappelleri JC; Hauber B; Klein K; Russo L; Viktrup L; Walsh D
Osteoarthritis Cartilage; 2020 Sep; 28(9):1202-1213. PubMed ID: 32652238
[TBL] [Abstract][Full Text] [Related]
39. Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).
Carlson KV; Rovner ES; Nair KV; Deal AS; Kristy RM; Schermer CR
Adv Ther; 2019 Aug; 36(8):1906-1921. PubMed ID: 31222714
[TBL] [Abstract][Full Text] [Related]
40. The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder.
Cameron AP; Chung DE; Dielubanza EJ; Enemchukwu E; Ginsberg DA; Helfand BT; Linder BJ; Reynolds WS; Rovner ES; Souter L; Suskind AM; Takacs E; Welk B; Smith AL
J Urol; 2024 Jul; 212(1):11-20. PubMed ID: 38651651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
